Abstract:ID 91703 Poster Board 477 Cancer patients commonly experience neuropathic pain caused by off-target effects of their chemotherapeutic treatments known as chemotherapy-induced peripheral neuropathy (CIPN), or by tumor metastasis to bone known as cancer-induced bone pain (CIBP). There are currently no treatments for either of these cancer-related neuropathies and current clinical regimens focus on symptom management. Current treatments have limited therapeutic windows due to negative side effects associated with utilized therapeutics that include opioids, anti-depressants, and gabapentinoids. A recently synthesized allosteric modulator of the g-protein activated inwardly rectifying potassium channels (GIRK) 1 and 2, known as GAT-1508, may be able to provide effective anti-allodynic effects with an improved therapeutic window. Utilizing CIPN and CIBP preclinical models, we assessed whether GAT-1508 would attenuate cancer-related mechanical allodynia. The CIPN model was induced in male and female C57BL/6 mice via a dosing cycle (8 mg/kg ip, given every other day, 32 mg/kg cumulative) of paclitaxel, a chemotherapeutic agent. The CIBP neuropathic pain model was induced in male and female C3H/HeJ mice, a mouse strain that is syngeneic to the murine fibrosarcoma cell line, NCTC-2472. Following implantation of NCTC-2472 fibrosarcoma cells into the calcaneus bone, mice exhibited mechanical allodynia associated with bone tumor metastasis. Vehicle injection served as a control and the von Frey assay was utilized to assess mechanical allodynia in both models. GAT-1508 (17.8–100 mg/kg, ip) dose-relatedly attenuated CIPN-induced mechanical allodynia (F (1.42, 21.36) = 485.6, p < 0.0001). Similarly, GAT-1508 dose-relatedly attenuated CIBP-induced mechanical allodynia (F 1.3, 9.1) = 22.64, p < 0.001). Additionally, at the highest dose tested (100 mg/kg, i.p.), GAT-1508 did not alter locomotor behavior, including distance ( p = 0.71) and speed ( p = 0.77). GAT-1508 dose-relatedly attenuated mechanical allodynia in both models. Given that no locomotor effects were observed, GAT-1508 may provide therapeutic effects with an improved therapeutic window and limited side-effects. Ultimately, these findings support further development and study of GIRK channel modulation for potential neuropathic pain therapeutics.

Go-sha-jinki-Gan (GJG) ameliorates allodynia in chronic constriction injury-model mice via suppression of TNF-α expression in the spinal cord

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Spinal NF-kB upregulation contributes to hyperalgesia in a rat model of advanced osteoarthritis

Mechanism of Ginkgolide B Amelioration of Neuropathic Pain Induced by Chronic Constriction Injury

EFFECT OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON RAT NEUROPATHIC PAIN

Analgesic Effect of SKI306X on Chronic Postischemic Pain and Spinal Nerve Ligation-Induced Neuropathic Pain in Mice

The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance

[6]-Shogaol and [6]-Gingerol active ingredients may improve neuropathic pain by suppressing cytokine levels in an experimental model

Ginkgolide B effectively mitigates neuropathic pain by suppressing the activation of the NLRP3 inflammasome through the induction of mitophagy in rats

Effectiveness of the Traditional Japanese Medicine Goshajinkigan in Preventing Paclitaxel-Induced Peripheral Neuropathy: A Multicenter Randomized Comparative Trial

The gap junction inhibitor INI-0602 attenuates mechanical allodynia and depression-like behaviors induced by spared nerve injury in rats

Intrathecal gastrodin alleviates allodynia in a rat spinal nerve ligation model through NLRP3 inflammasome inhibition

Glial cell line-derived neurotrophic factor contributes to delayed inflammatory hyperalgesia in adjuvant rat pain model.

The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats

TLR4 Inhibits Spinal Gabaergic Activities Via Microglial Activation in Chronic Constriction Injury Mice

Inhibiting the JNK Signaling Pathway Attenuates Hypersensitivity and Anxiety-Like Behavior in a Rat Model of Non-specific Chronic Low Back Pain

Effects of Ginkgo Biloba Extract EGb-761 on Neuropathic Pain in Mice: Involvement of Opioid System.

Effect and Mechanism of Inhibition of PI3K/Akt/mTOR Signal Pathway on Chronic Neuropathic Pain and Spinal Microglia in a Rat Model of Chronic Constriction Injury.

Bogijetong decoction and its active herbal components protect the peripheral nerve from damage caused by taxol or nerve crush

Assessment of an Allosteric Modulator of GIRK 1/2 in Preclinical Models of Cancer-Related Neuropathies to Alleviate Associated Mechanical Allodynia